Currently, patients with severe asthma are prescribed biologics depending on the phenotype that is identified using certain biomarkers (sputum and blood eosinophil counts, serum IgE, exhaled nitric oxide, and serum periostin) [15]. This evidence concerns the gene IGHE and asthma.